title: The effect of fuel source on amino acid metabolism in critically ill patients.
abstract: The ideal energy substrate for critically ill patients receiving total parenteral nutrition (TPN) remains controversial. While glucose has been proved to have nitrogen sparing properties in postoperative patients, critically ill patients tolerate glucose loads poorly and fat appears to be an obligatory fuel in sepsis. Furthermore, it is not yet certain whether the changes in whole body protein metabolism induced by critical illness are influenced by the nature of the TPN provided. This study was conducted on patients admitted to a surgical intensive care unit (SICU) who fulfilled the criteria of requiring TPN and mechanical ventilation for at least four days. Patients were randomized to receive either glucose (G) or equicaloric proportions of glucose and lipid (GF) as an intravenous energy source. TPN was commenced early, within 24-48 hr of trauma or surgery and admission to the ICU. Nonprotein calorie intake was 125% of calculated basal energy expenditure. Nitrogen balance was calculated from 24-hr urinary urea excretion. Protein synthesis, turnover, and catabolism were measured on Day 4 of the study using an established radiolabeled C14-leucine technique. Degree of sepsis and illness were calculated using published scores. Fifty patients entered the trial but 32 were excluded by Day 4. Of the 18 patients completing an initial four day study, eight went on to complete a second study on the alternative regimen--a total of 26 studies (14 G, 12 GF). Net protein synthesis was achieved in 18 studies (12 G, 6 FG) and positive nitrogen balance by Day 4 in 22 studies. Four patients on the G regimen were withdrawn due to glucose intolerance while none of the patients on GF developed glucose intolerance or hyperlipidaemia. Both whole body protein synthesis and catabolism correlated significantly with degree of sepsis. The type of TPN fuel used, G and GF, did not appear to influence whole body protein dynamics, both regimens achieving greatly improved whole body protein kinetics.
authors.affiliation: Surgical Intensive Care Unit, Groote Schuur Hospital, Cape Town, South Africa.
authors.forename: T M
authors.initials: TM
authors.lastname: de Chalain
authors.forename: W L
authors.initials: WL
authors.lastname: Michell
authors.forename: S J
authors.initials: SJ
authors.lastname: O'Keefe
authors.forename: J M
authors.initials: JM
authors.lastname: Ogden
mesh_terms: D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000378:metabolism*; D003422:Critical Care; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage*; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010288:Parenteral Nutrition; D011506:Proteins / Q000493:pharmacokinetics; D014508:Urea / Q000097:blood / Q000652:urine
chemical_list: D000596:Amino Acids; D005217:Fat Emulsions, Intravenous; D011506:Proteins; D014508:Urea; D005947:Glucose